Sign in with your email address username.


[Comment] Taking the pulse of atrial fibrillation

Atrial fibrillation is a highly prevalent disease and a growing health-care burden worldwide.1 By the middle of the 21st century, about 25 million people are expected to be affected by atrial fibrillation in Europe and North America.2,3 With the ageing demographics of most developed countries, and with people with atrial fibrillation living longer than before, the predicted financial cost of atrial fibrillation4 and its sequelae make it imperative to understand determinants in the population, as well as the effect of interventions to reduce disease burden.